RGEN,ASRT Stock Price and Quote

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -3.81
Percentage change -2.84	%

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: IJH VTI VB VXF VBK MDY IBB FBT SPMD IWR

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	5.46%	Shs Outstand	56.18M	Perf Week	2.13%
Market Cap	7.31B	Forward P/E	59.58	EPS next Y	2.19	Insider Trans	-1.70%	Shs Float	53.12M	Perf Month	-2.02%
Enterprise Value	7.30B	PEG	-	EPS next Q	0.39	Inst Own	102.38%	Short Float	7.09%	Perf Quarter	5.12%
Income	-22.98M	P/S	11.25	EPS this Y	6.63%	Inst Trans	2.18%	Short Ratio	4.90	Perf Half Y	-15.19%
Sales	650.43M	P/B	3.68	EPS next Y	29.71%	ROA	-0.81%	Short Interest	3.77M	Perf YTD	-9.55%
Book/sh	35.34	P/C	10.49	EPS next 5Y	21.24%	ROE	-1.16%	52W High	182.52 -28.67%	Perf Year	7.76%
Cash/sh	12.41	P/FCF	61.09	EPS past 3/5Y	- -	ROIC	-0.87%	52W Low	102.96 26.44%	Perf 3Y	-22.71%
Dividend Est.	-	EV/EBITDA	58.62	Sales past 3/5Y	-1.83% 18.61%	Gross Margin	46.39%	Volatility	3.76% 3.63%	Perf 5Y	2.84%
Dividend TTM	-	EV/Sales	11.22	EPS Y/Y TTM	-196.93%	Oper. Margin	4.15%	ATR (14)	4.81	Perf 10Y	225.15%
Dividend Ex-Date	-	Quick Ratio	5.79	Sales Y/Y TTM	4.88%	Profit Margin	-3.53%	RSI (14)	55.68	Recom	1.57
Dividend Gr. 3/5Y	- -	Current Ratio	6.79	EPS Q/Q	76.84%	SMA20	3.74%	Beta	1.06	Target Price	181.65
Payout	-	Debt/Eq	0.34	Sales Q/Q	10.44%	SMA50	2.73%	Rel Volume	0.98	Prev Close	134.00
Employees	1778	LT Debt/Eq	0.34	Earnings	Apr 29 BMO	SMA200	-7.65%	Avg Volume	769.20K	Price	130.19
IPO	Apr 29, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.68% 3.35%	Trades		Volume	753,929	Change	-2.84%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-24-25	Initiated	Barclays	Overweight	$150
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$241
Aug-24-20	Reiterated	H.C. Wainwright	Buy	$151 → $168
Jun-30-20	Reiterated	H.C. Wainwright	Buy	$143 → $151

Show Previous Ratings

Jun-24-25 02:18PM	5 Insightful Analyst Questions From Repligen's Q1 Earnings Call (StockStory)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-04-25 11:36PM	Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-03-25 11:32PM	Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers (StockStory)
Jun-02-25 01:36PM	Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? (Zacks)
11:30AM	Loading…
May-29-25 11:30AM	Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? (Zacks)
May-27-25 07:30AM	Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report (GlobeNewswire)
May-22-25 07:30AM	Repligen Corporation to Present at William Blair Growth Conference (GlobeNewswire)
May-09-25 12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-07-25 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
08:18AM	Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare (Insider Monkey)
May-01-25 12:11PM	Jim Cramer on Repligen Corporation (RGEN): 'I'm Not Quite Ready to Stick My Neck Out on This One' (Insider Monkey)
Apr-30-25 04:19PM	RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty (StockStory)
10:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
09:07AM	Loading…
09:07AM	Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
03:09AM	Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
12:58PM	Repligen Corporation (RGEN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:05AM	Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:45AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 07:08PM	What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings (GuruFocus.com)
03:08AM	Repligen (RGEN) Q1 Earnings: What To Expect (StockStory)
Apr-25-25 09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:01AM	Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) +5.54%
Apr-16-25 11:40AM	GMAB or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
07:30AM	Loading…
Apr-15-25 07:30AM	Repligen to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-10-25 05:03AM	Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -6.99%
Apr-08-25 07:30AM	Repligen Appoints Jacob Johnson As Vice President Investor Relations (GlobeNewswire) -6.22%
04:11AM	Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-25-25 12:46PM	Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? (Insider Monkey)
Mar-20-25 07:52AM	Repligen: Ongoing Bioprocessing Market Recovery (SeekingAlpha)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:01AM	Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks (StockStory)
Mar-11-25 05:01AM	A Look Back at Drug Development Inputs & Services Stocks Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack (StockStory) +7.40%
Mar-10-25 08:06PM	Analyst Report: Repligen Corporation (Morningstar Research) -12.02%
Mar-06-25 08:02AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Mar-05-25 05:14AM	Q4 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Mar-04-25 01:26PM	908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth (Benzinga)
07:30AM	Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices (Business Wire)
Feb-21-25 04:28PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:06AM	Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:24AM	Q4 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-20-25 07:21PM	Analyst Report: Repligen Corporation (Morningstar Research) +7.92%
02:00PM	Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook (Benzinga)
08:54AM	What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings (GuruFocus.com)
08:45AM	Repligen (RGEN) Beats Q4 Earnings Estimates (Zacks)
08:08AM	Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates (StockStory)
07:50AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-19-25 08:05AM	Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow (StockStory)
Feb-12-25 08:44PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:17AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Feb-11-25 07:30AM	Repligen to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-29-25 03:19AM	Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains? (Zacks)
Jan-13-25 07:18PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-07-25 07:30AM	Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-06-25 07:30AM	Repligen Launches the CTech SoloVPE PLUS System (GlobeNewswire)
Dec-20-24 09:21AM	Repligen Corporation (RGEN) Fell Along with Peers (Insider Monkey)
Dec-18-24 09:40PM	Analyst Report: Repligen Corporation (Morningstar Research) -6.83%
Dec-16-24 07:43PM	Analyst Report: Repligen Corporation (Morningstar Research)
08:11AM	BioLife Solutions Appoints Tony J. Hunt to its Board of Directors (PR Newswire)
Dec-12-24 11:30AM	Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? (Zacks)
07:30AM	Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report (GlobeNewswire)
Dec-09-24 09:03AM	Several Factors Lifted Repligen Corporation (RGEN) in Q3 (Insider Monkey)
07:30AM	Repligen Launches Novel AVIPure dsRNA Resin in OPUS Pre-packed Columns (GlobeNewswire)
Nov-13-24 09:54AM	Analyst Report: Repligen Corporation (Morningstar Research)
02:37AM	Q3 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
02:08AM	Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-12-24 11:55AM	Repligen Stock Soars 10% on Record Growth and Bold Moves (GuruFocus.com) +6.51%
09:05AM	Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 07:04AM	Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 07:30AM	Repligen to Report Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-22-24 10:01AM	Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-15-24 12:45PM	3 investable themes, categories outside of the AI trade (Yahoo Finance Video)
Oct-04-24 11:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Oct-03-24 11:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
Sep-24-24 07:30AM	Repligen Opens Training & Innovation Center to Elevate Customer Experience (GlobeNewswire)
Sep-11-24 06:35AM	Several Headwinds Dragged Repligen Corporation (RGEN) in Q2 (Insider Monkey)
Sep-09-24 05:20AM	Reasons for the Decline of Repligen (RGEN) in Q2 (Insider Monkey)
Sep-07-24 07:37AM	Repligen Corporation (RGEN) Fell Due to CEO Transition (Insider Monkey)
Aug-29-24 11:31AM	Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-23-24 08:43AM	Repligen Corporation (RGEN) Benefitted From Drug Approval (Insider Monkey)
07:30AM	Repligen Corporation to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-16-24 04:39AM	Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)? (Insider Monkey) -9.26%
Aug-02-24 07:09AM	Here's Why Shares in This Hot Healthcare Stock Surged This Week (Motley Fool)
Jul-31-24 10:46AM	Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates (Zacks)
12:30AM	Q2 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-30-24 08:45AM	Repligen (RGEN) Q2 Earnings Meet Estimates (Zacks) +16.37%
07:45AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2024 Financial Results (GlobeNewswire)
02:55AM	Should You Consider Investing in Repligen Corporation (RGEN)? (Insider Monkey)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunt Anthony	Director	May 15 '25	Sale	123.71	26,447	3,271,688	109,854	May 16 03:02 PM
Hunt Anthony	Director	May 15 '25	Proposed Sale	128.34	26,447	3,394,208		May 15 10:25 AM
Hunt Anthony	Director	Mar 17 '25	Option Exercise	54.73	26,756	1,464,267	163,057	Mar 19 04:21 PM
Hunt Anthony	Director	Mar 17 '25	Sale	152.51	26,756	4,080,663	136,301	Mar 19 04:21 PM
Pax Margaret	Director	Mar 17 '25	Buy	150.69	250	37,672	1,043	Mar 18 03:58 PM
Hunt Anthony	Director	Mar 17 '25	Proposed Sale	150.42	26,756	4,024,638		Mar 17 10:04 AM
Hunt Anthony	Director	Dec 05 '24	Option Exercise	33.87	11,808	399,937	151,648	Dec 05 08:26 PM
Hunt Anthony	Director	Nov 21 '24	Option Exercise	33.87	24,246	821,212	164,086	Nov 22 04:52 PM
Hunt Anthony	Director	Nov 21 '24	Sale	139.67	24,246	3,386,439	139,840	Nov 22 04:52 PM
Anthony Hunt	Executive Chairman	Nov 21 '24	Proposed Sale	139.66	24,246	3,386,311		Nov 21 03:52 PM
MUIR GLENN P	Director	Nov 19 '24	Option Exercise	36.29	19,000	689,510	32,283	Nov 20 02:29 PM
Hunt Anthony	Director	Sep 10 '24	Option Exercise	33.87	10,000	338,700	162,031	Sep 12 11:35 AM
Hunt Anthony	Director	Sep 10 '24	Sale	145.37	22,191	3,225,927	139,840	Sep 12 11:35 AM
Hunt Anthony	Officer	Sep 10 '24	Proposed Sale	144.72	22,191	3,211,481		Sep 10 04:03 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Option Exercise	86.10	175	15,067	12,463	Aug 05 09:56 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Sale	159.35	7,148	1,139,016	12,288	Aug 05 09:56 PM
Ralf Kuriyel	Senior Vice President	Aug 02 '24	Proposed Sale	159.35	7,148	1,139,040		Aug 02 03:26 PM
KURIYEL RALF	Senior VP, R&D	Aug 01 '24	Sale	165.67	4,465	739,717	19,261	Aug 01 08:47 PM
MUIR GLENN P	Director	Aug 01 '24	Option Exercise	36.29	5,000	181,450	13,283	Aug 01 05:04 PM
Christine Gebski	Senior Vice President	Aug 01 '24	Proposed Sale	167.00	2,160	360,720		Aug 01 04:11 PM
Ralf Kuriyel	Senior Vice President	Aug 01 '24	Proposed Sale	165.67	4,465	739,705		Aug 01 04:07 PM

Dollar change -0.0191
Percentage change -2.69	%

ASRT Assertio Holdings Inc daily Stock Chart

Peers: SFM OIS DCTH HRTX PBPB MYE OPI NUS FET TSE

| Held by: VTI VXF PRFZ BSVO RFLR

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	3.38%	Shs Outstand	95.77M	Perf Week	5.82%
Market Cap	66.18M	Forward P/E	-	EPS next Y	-0.08	Insider Trans	0.00%	Shs Float	92.54M	Perf Month	4.55%
Enterprise Value	24.62M	PEG	-	EPS next Q	-0.08	Inst Own	26.78%	Short Float	6.33%	Perf Quarter	19.82%
Income	-30.61M	P/S	0.56	EPS this Y	-37.39%	Inst Trans	-12.69%	Short Ratio	22.14	Perf Half Y	-19.83%
Sales	119.00M	P/B	0.61	EPS next Y	73.89%	ROA	-10.77%	Short Interest	5.86M	Perf YTD	-20.68%
Book/sh	1.13	P/C	0.76	EPS next 5Y	-	ROE	-25.19%	52W High	1.80 -61.57%	Perf Year	-56.81%
Cash/sh	0.91	P/FCF	10.41	EPS past 3/5Y	-96.84% 55.01%	ROIC	-19.88%	52W Low	0.51 34.51%	Perf 3Y	-78.27%
Dividend Est.	-	EV/EBITDA	7.72	Sales past 3/5Y	4.02% -11.45%	Gross Margin	45.18%	Volatility	5.06% 5.06%	Perf 5Y	-78.82%
Dividend TTM	-	EV/Sales	0.21	EPS Y/Y TTM	91.83%	Oper. Margin	-22.03%	ATR (14)	0.03	Perf 10Y	-99.17%
Dividend Ex-Date	-	Quick Ratio	1.35	Sales Y/Y TTM	-16.23%	Profit Margin	-25.72%	RSI (14)	57.74	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.66	EPS Q/Q	-197.89%	SMA20	5.55%	Beta	0.28	Target Price	2.80
Payout	-	Debt/Eq	0.42	Sales Q/Q	-18.37%	SMA50	5.48%	Rel Volume	0.36	Prev Close	0.71
Employees	58	LT Debt/Eq	0.42	Earnings	May 12 AMC	SMA200	-15.49%	Avg Volume	264.79K	Price	0.69
IPO	Dec 02, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	-133.33% -3.77%	Trades		Volume	94,393	Change	-2.69%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-24	Initiated	Maxim Group	Buy	$3
Jul-03-24	Initiated	H.C. Wainwright	Buy	$4
Nov-07-22	Initiated	Lake Street	Buy	$7
Nov-30-18	Downgrade	Mizuho	Buy → Neutral

Jul-08-25 06:28AM	New Strong Sell Stocks for July 8th (Zacks)
Jun-30-25 06:03AM	New Strong Sell Stocks for June 30th (Zacks)
Jun-25-25 06:26AM	New Strong Sell Stocks for June 25th (Zacks)
Jun-18-25 05:08AM	New Strong Sell Stocks for June 18th (Zacks)
May-19-25 04:10PM	Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025 (GlobeNewswire) +6.77%
05:38AM	Loading…
May-13-25 05:38AM	Q1 2025 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:09AM	Assertio Holdings Inc (ASRT) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-12-25 05:15PM	Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:20PM	Assertio: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Assertio Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-09-25 09:48AM	Assertio Holdings Inc (ASRT) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
May-08-25 05:40PM	OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-05-25 08:15AM	Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025 (GlobeNewswire) -6.46%
Apr-07-25 09:17AM	Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains? (Zacks) -6.19%
Mar-21-25 09:00AM	iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 (ACCESSWIRE)
09:10AM	Loading…
Mar-20-25 09:10AM	Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025 (GlobeNewswire)
Mar-13-25 12:58PM	Q4 2024 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -7.46%
03:08AM	Assertio Holdings Inc (ASRT) Q4 2024 Earnings Call Highlights: Strategic Growth Amidst Challenges (GuruFocus.com)
Mar-12-25 04:30PM	Assertio: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Assertio Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-05-25 04:05PM	Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 (GlobeNewswire) +6.49%
Jan-03-25 04:30PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-17-24 08:30AM	Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors (GlobeNewswire)
Dec-13-24 08:00AM	Assertio Announces Results of Rolvedon (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study (GlobeNewswire)
Dec-12-24 08:00AM	Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO (GlobeNewswire)
Dec-06-24 07:00AM	Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer (GlobeNewswire)
Nov-15-24 09:00AM	Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio (Business Wire)
Nov-12-24 09:41AM	Q3 2024 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -7.89%
Nov-11-24 04:09PM	Assertio: Q3 Earnings Snapshot (Associated Press Finance) +8.82%
04:02PM	Assertio Reports Third Quarter 2024 Financial Results (GlobeNewswire)
03:41PM	Loading…
03:41PM	Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio (Business Wire)
07:30AM	Assertio Provides Response to Letter from Short-seller (GlobeNewswire)
Nov-08-24 09:00AM	Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud (Business Wire) -15.84%
07:06AM	Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-30-24 08:00AM	Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024 (GlobeNewswire)
Oct-11-24 08:00AM	Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 (GlobeNewswire)
Oct-09-24 05:18PM	Assertio Holdings Inc (ASRT) Q2 2024 Earnings Call Highlights: Navigating Sales Challenges and ... (GuruFocus.com)
Oct-04-24 04:05PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-03-24 04:05PM	Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024 (GlobeNewswire) -5.93% +10.81%
Aug-07-24 04:47PM	Assertio: Q2 Earnings Snapshot (Associated Press Finance) -11.79%
04:01PM	Assertio Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-24-24 04:05PM	Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire) -6.17%
09:00AM	Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc. (Business Wire)
Jul-09-24 04:30PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +8.11%
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-06-24 04:05PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-05-24 08:30AM	Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024 (GlobeNewswire)
May-29-24 07:00AM	Assertio Announces the Appointment of Brendan P. O'Grady as New CEO (GlobeNewswire)
May-17-24 09:15AM	Assertio to Participate in Benchmark Healthcare Conference on May 21-22 (GlobeNewswire)
07:30AM	BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS (PR Newswire)
May-16-24 09:16AM	Assertio to Participate in AGP Healthcare Conference on May 21 (GlobeNewswire)
May-13-24 05:52PM	BUXTON HELMSLEY URGES ASSERTIO STOCKHOLDERS TO VOTE 'AGAINST' DIRECTORS AFTER DISCLOSURE FAILURES, INAPPROPRIATE BOARDROOM ACTIVITY, STRATEGIC BLUNDERS (PR Newswire) +9.38%
May-10-24 03:12PM	Assertio to Present at the Citizens JMP Life Sciences Conference in New York City (GlobeNewswire) -8.57%
May-07-24 10:28AM	Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Call Transcript (Insider Monkey) -9.02%
05:35AM	Q1 2024 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:10AM	Assertio Holdings Inc (ASRT) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ... (GuruFocus.com)
May-06-24 08:59PM	ASRT Stock Earnings: Assertio Holdings Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +18.45%
05:46PM	Assertio Holdings Inc (ASRT) Surpasses Revenue Estimates But Reports Wider Loss in Q1 2024 (GuruFocus.com)
04:21PM	Assertio: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Assertio Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-25-24 08:00AM	Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024 (GlobeNewswire) -9.30%
Apr-03-24 08:00AM	Sig Kirk Joins Assertio Board of Directors (GlobeNewswire)
Apr-01-24 09:00AM	Assertio to Present at LD Micro Invitational Conference in New York City (GlobeNewswire)
Mar-12-24 11:11AM	Assertio Holdings Inc (ASRT) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com) +8.06%
08:31AM	Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:49AM	Q4 2023 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-11-24 04:26PM	Assertio: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Assertio Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-04-24 05:07PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Feb-29-24 04:05PM	Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024 (GlobeNewswire)
Feb-28-24 10:15AM	Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Investors of March 5, 2024 Lead Plaintiff Deadline and Urges Investors with Substantial Losses to Contact the Firm (PR Newswire)
Feb-26-24 07:57PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Feb-23-24 11:30AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
05:45AM	Investors in Assertio Holdings, Inc. Should Contact Levi & Korsinsky Before March 5, 2024 to Discuss Your Rights - ASRT (PR Newswire)
Feb-22-24 12:35PM	Assertio Holdings, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky for More Information ASRT (GlobeNewswire)
Feb-19-24 12:39PM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Feb-16-24 12:41PM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire)
11:28AM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire)
Feb-13-24 05:45AM	Shareholders of Assertio Holdings, Inc. Should Contact Levi & Korsinsky Before March 5, 2024 to Discuss Your Rights - ASRT (PR Newswire) -7.27%
Feb-12-24 10:30AM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire) +7.90%
Feb-09-24 02:51PM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Feb-05-24 03:56PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
10:24AM	Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why (Zacks)
10:08AM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Feb-02-24 12:32PM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire)
12:19PM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire)
Jan-29-24 12:30PM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire) +5.96%
Jan-26-24 09:15AM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Jan-24-24 06:54PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
10:15AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-22-24 03:42PM	Assertio Holdings (ASRT) Faces Lawsuit as Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire)
Jan-19-24 09:36AM	Assertio Holdings, Inc. (NASDAQ: ASRT) Securities Fraud: Contact Berger Montague To Discuss Your Rights (GlobeNewswire)
Jan-17-24 10:15AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
09:35AM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire)
Jan-15-24 03:29PM	Assertio Holdings (ASRT) Faces Lawsuit After CEO Sacked Hagens Berman (GlobeNewswire)
Jan-10-24 10:45AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-08-24 12:14PM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire) -5.39%
Jan-05-24 06:56PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +12.79%
Jan-04-24 09:46AM	Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO (Zacks) -10.91%
Jan-03-24 08:59AM	Assertio Holdings, Inc. Announces Leadership Transition (GlobeNewswire) -10.96%

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Grady Brendan P.	CEO	May 31 '25	Option Exercise	0.00	166,665	0	178,371	Jun 03 06:00 PM
Schlessinger Sam	EVP, General Counsel	May 12 '25	Option Exercise	0.00	38,017	0	191,906	May 14 06:03 PM
Schwichtenberg Paul	See Remarks	May 12 '25	Option Exercise	0.00	38,017	0	184,362	May 14 06:01 PM
Patel Ajay	EVP and CFO	May 12 '25	Option Exercise	0.00	38,017	0	213,692	May 14 06:00 PM
Schlessinger Sam	SVP, General Counsel	Feb 21 '25	Option Exercise	0.00	17,150	0	161,545	Feb 25 06:03 PM
Schwichtenberg Paul	See Remarks	Feb 21 '25	Option Exercise	0.00	17,150	0	154,850	Feb 25 06:02 PM
Patel Ajay	SVP and CFO	Feb 21 '25	Option Exercise	0.00	17,150	0	184,180	Feb 25 06:00 PM
Schlessinger Sam	SVP, General Counsel	Feb 07 '25	Option Exercise	0.00	21	0	153,698	Feb 11 06:13 PM
Schwichtenberg Paul	See Remarks	Feb 07 '25	Option Exercise	0.00	25,000	0	150,101	Feb 11 06:11 PM
Patel Ajay	SVP and CFO	Feb 07 '25	Option Exercise	0.00	25,000	0	179,431	Feb 11 06:09 PM
Mason Heather L	Director	Nov 18 '24	Buy	0.80	75,000	60,000	287,650	Nov 19 09:02 AM
O'Grady Brendan P.	CEO	Nov 14 '24	Buy	0.85	11,706	9,950	11,706	Nov 15 02:43 PM
Schlessinger Sam	SVP, General Counsel	Oct 01 '24	Option Exercise	0.00	19,404	0	141,459	Oct 03 07:00 PM

RGEN

Repligen Corp

ASRT

Assertio Holdings Inc

Upgrade your FINVIZ experience